VOLUME
65 2004 NUMBER 4
CME Pretest 459
CME Posttest 588
Brainstorms
460 Anticonvulsants as Anxiolytics, Part 2: Pregabalin and
Gabapentin as α2δ Ligands at Voltage-Gated Calcium
Channels. Stephen M. Stahl
[PDF]
Editorial
462 Sex and Psychiatry in the Next 5 Years. Katherine L.
Wisner
[PDF]
Original Articles
464 Neuroleptic Malignant Syndrome and Atypical Antipsychotic
Drugs. Jambur Ananth, Sharat Parameswaran, Sarath Gunatilake,
Karl Burgoyne, and Taghrid Sidhom
[Abstract]
[PDF]
471 Managing Atypical Antipsychotic-Associated Weight Gain:
12-Month Data on a Multimodal Weight Control Program. Matthew
Menza, Betty Vreeland, Shula Minsky, Michael Gara, Diane Rigassio
Radler, and Marie Sakowitz
[Abstract]
[PDF]
478 A Multicenter, Randomized, Double-Blind,
Placebo-Controlled Trial of Extended-Release Carbamazepine
Capsules as Monotherapy for Bipolar Disorder Patients With Manic
or Mixed Episodes. Richard H. Weisler, Amir H. Kalali, Terence
A. Ketter, and the SPD417 Study Group
[Abstract]
[PDF]
485 Speed of Response and Remission in Major Depressive
Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium
for Research in ECT (CORE) Report. [CME]
Mustafa M. Husain, A. John Rush, Max Fink, Rebecca Knapp,
Georgios Petrides, Teresa Rummans, Melanie M. Biggs, Kevin
O'Connor, Keith Rasmussen, Marc Litle, Wenle Zhao, Hilary J.
Bernstein, Glenn Smith, Martina Mueller, Shawn M. McClintock,
Samuel H. Bailine, and Charles H. Kellner
[Abstract]
[PDF]
492 Hippocampal and Amygdala Changes in Patients With Major
Depressive Disorder and Healthy Controls During a 1-Year
Follow-Up. Thomas Frodl, Eva M. Meisenzahl, Thomas Zetzsche,
Tom Höhne, Sandra Banac, Constanze Schorr, Markus Jäger, Gerda
Leinsinger, Ronald Bottlender, Maximilian Reiser, and
Hans-Jürgen Möller
[Abstract]
[PDF]
500 The Texas Medication Algorithm Project Antipsychotic
Algorithm for Schizophrenia: 2003 Update. Alexander L. Miller,
Catherine S. Hall, Robert W. Buchanan, Peter F. Buckley, John A.
Chiles, Robert R. Conley, M. Lynn Crismon, Larry Ereshefsky,
Susan M. Essock, Molly Finnerty, Stephen R. Marder, Del D.
Miller, Joseph P. McEvoy, A. John Rush, Sy A. Saeed, Nina R.
Schooler, Steven P. Shon, Scott Stroup, and Bernardo Tarin-Godoy
[Abstract]
[PDF]
509 Suicide Attempts and Ideation in Patients With Bipolar I
Disorder. Andrea Fagiolini, David J. Kupfer, Paola Rucci, John
A. Scott, Danielle M. Novick, and Ellen Frank
[Abstract]
[PDF]
515 Effect of Reboxetine on Major Depressive Disorder in
Breast Cancer Patients: An Open-Label Study. Luigi Grassi,
Bruno Biancosino, Luciana Marmai, and Roberto Righi
[Abstract]
[PDF]
521 The Effect of Duloxetine on Painful Physical Symptoms in
Depressed Patients: Do Improvements in These Symptoms Result in
Higher Remission Rates? Maurizio Fava, Craig H. Mallinckrodt,
Michael J. Detke, John G. Watkin, and Madelaine M. Wohlreich
[Abstract]
[PDF]
531 Health-Related Quality of Life in Patients With
Schizophrenia During Treatment With Long-Acting, Injectable
Risperidone. Henry A. Nasrallah, Inge Duchesne, Angelika
Mehnert, Carmela Janagap, and Mariëlle Eerdekens
[Abstract]
[PDF]
537 Lack of Effect of Intravenous Immunoglobulins on Tics: A
Double-Blind Placebo-Controlled Study. Pieter J. Hoekstra,
Ruud B. Minderaa, and Cees G. M. Kallenberg
[Abstract]
[PDF]
543 Somatic Symptoms as Predictors of Time to Onset of
Response to Fluoxetine in Major Depressive Disorder. George I.
Papakostas, Timothy J. Petersen, Dan V. Iosifescu, Paul
Summergrad, Katherine G. Sklarsky, Jonathan E. Alpert, Andrew A.
Nierenberg, and Maurizio Fava
[Abstract]
[PDF]
547 Hyperlipidemia in Persons Using Antipsychotic Medication:
A General Population-Based Birth Cohort Study. Kaisa Saari,
Hannu Koponen, Jaana Laitinen, Jari Jokelainen, Liisa Lauren,
Matti Isohanni, and Sari Lindeman
[Abstract]
[PDF]
551 Effects of Atypical Antipsychotics on the Syndromal
Profile in Treatment-Resistant Schizophrenia. [CME] Jean-Pierre Lindenmayer,
Pal Czobor, Jan Volavka, Jeffrey A. Lieberman, Leslie Citrome,
Brian Sheitman, Joseph P. McEvoy, Thomas B. Cooper, and Miranda
Chakos
[Abstract]
[PDF]
557 Development of an Atherogenic Metabolic Risk Factor
Profile Associated With the Use of Atypical Antipsychotics.
Natalie Alméras, Jean-Pierre Després, Julie Villeneuve,
Marie-France Demers, Marc-André Roy, Camille Cadrin, Jean-Pierre
Mottard, and Roch-Hugo Bouchard
[Abstract]
[PDF]
565 Augmentation of Serotonin Reuptake Inhibitors in
Refractory Obsessive-Compulsive Disorder Using Adjunctive
Olanzapine: A Placebo-Controlled Trial. Alexander Bystritsky,
Deborah L. Ackerman, Richard M. Rosen, Tanya Vapnik, Eda Gorbis,
Karron M. Maidment, and Sanjaya Saxena
[Abstract]
[PDF]
Academic Highlights
569 International Consensus Group on Bipolar I Depression
Treatment Guidelines.
[PDF]
Letters To the Editor
580 Lack of Association Between Plasma Apolipoprotein E and
Suicide Attempts. Enrique Baca-Garcia, Carmen Diaz-Sastre,
Eloy García-Resa, Antonio Ceverino, Antonio Ramirez, Jeronimo
Saiz-Ruiz, and Jose de Leon
[PDF]
581 Ribavirin May Be an Important Factor in IFN-Induced
Neuropsychiatric Effects. Gregory M. Asnis, Richard De La
Garza II, Andrew H. Miller, and Charles L. Raison
[PDF]
- Reply by Michael R. Kraus and Arne Schäfer
582 Olanzapine May Cause Delirium in Geriatric Patients.
Steven Samuels and Margaret Fang
[PDF]
583 A Case of Tardive Dystonia Successfully Managed With
Quetiapine. Yukiya Sasaki, Ichiro Kusumi, and Tsukasa Koyama
[PDF]
584 A Rose by Any Other Name. Bruce Sutor
[PDF]
Book Reviews 585
Worldview of psychiatry 586
NOW @ Psychiatrist.com 590
Information for authors
see www.psychiatrist.com/author.htm